THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 117 filers reported holding THERAVANCE INC in Q4 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $573,000 | -82.6% | 79,756 | -56.1% | 0.00% | -66.7% |
| Q2 2015 | $3,284,000 | +104.2% | 181,752 | +77.6% | 0.00% | +50.0% |
| Q1 2015 | $1,608,000 | -27.4% | 102,364 | -34.6% | 0.00% | 0.0% |
| Q4 2014 | $2,216,000 | +23.9% | 156,571 | +49.5% | 0.00% | +100.0% |
| Q3 2014 | $1,789,000 | -68.0% | 104,724 | -44.1% | 0.00% | -80.0% |
| Q2 2014 | $5,583,000 | -24.7% | 187,423 | -21.8% | 0.01% | -28.6% |
| Q1 2014 | $7,418,000 | -22.3% | 239,737 | -10.5% | 0.01% | -22.2% |
| Q4 2013 | $9,545,000 | -17.8% | 267,780 | -5.8% | 0.01% | -25.0% |
| Q3 2013 | $11,618,000 | -0.0% | 284,276 | -5.7% | 0.01% | 0.0% |
| Q2 2013 | $11,621,000 | +158.2% | 301,605 | +58.3% | 0.01% | +140.0% |
| Q1 2013 | $4,501,000 | – | 190,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 16,538,977 | $637,247,000 | 15.84% |
| Litespeed Management, L.L.C. | 1,516,994 | $58,450,000 | 10.69% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,584,469 | $99,580,000 | 6.38% |
| Realm Partners LLC | 166,061 | $6,398,000 | 5.30% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 10,000 | $385,300,000 | 4.86% |
| SECTORAL ASSET MANAGEMENT INC | 3,167,118 | $122,029,000 | 3.61% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,004,316 | $231,346,000 | 2.92% |
| BB BIOTECH AG | 888,244 | $34,224,000 | 2.46% |
| Portolan Capital Management | 163,617 | $6,304,000 | 1.80% |
| Trellus Management Company, LLC | 20,000 | $771,000 | 0.98% |